RBC Capital Markets adjusted their outlook on Morgan Stanley (NYSE:MS) shares, raising the price target from $122.00 to ...

In a report released yesterday, Deane Dray from RBC Capital maintained a Sell rating on 3M (MMM – Research Report), with a price target of ...

RBC Capital Markets adjusted its stance on Intra-Cellular Therapies shares, downgrading the biopharmaceutical company from Outperform to Sector Perform. The firm, however, raised its price target on ...

RBC Capital analyst Mandeep Jagpal maintained a Sell rating on abrdn (ABDN – Research Report) today and set a price target of p135.00. The ...

The CEO also said he is ‘bullish’ on the potential for stock sales, including initial public offerings in 2025.

Morgan Stanley's profit more than doubled in the fourth quarter, fueled by a wave of dealmaking and stock sales that drove ...

Robinhood fined $65 million by SEC. Analysts bullish on company's growth potential in crypto industry under incoming Trump ...

RBC Capital Markets analyst Maurice Choy identifies relative “safer havens” in the yield-heavy energy infrastructure sector, ...

Research analysts at BMO Capital Markets began coverage on shares of Toast (NYSE:TOST – Get Free Report) in a report released on Monday,Benzinga reports. The brokerage set an “outperform” rating and a ...

Daniel Fannon; Analyst; Jefferies & Company Inc. Gerard Cassidy; Analyst; RBC Capital Markets ...